Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

MnSOD mimetic BMX-001

A third generation, cationic, lipophilic, manganese (Mn) and porphyrin-based mimetic of the human mitochondrial manganese superoxide dismutase (MnSOD), with antioxidant and potential chemoprotective activities. Upon administration, MnSOD mimetic BMX-001 is internalized by cells and mimics the activity of MnSOD by scavenging reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and hydroxyl radical. This prevents oxidative damage to macromolecules such as DNA and minimizes oxygen free radical-related chemotoxicity in normal tissues. This agent was designed to be more lipophilic and less toxic than first and second generation Mn-porphyrin mimetics.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:manganese (III) ortho N-butoxyethylpyridylporphyrin
mitochondrial manganese superoxide dismutatse mimetic BMX-001
Code name:BMX-001
Chemical structure:manganese butoxyethyl pyridyl porphyrin; Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin (SY); MnTnBuOE-3-PyP 5+
manganese(5+), ((2,2',2'',2'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis(1-(2-butoxyethyl)pyridiniumato))(2-))-, chloride (1:5), (sp-4-1)-
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search